Literature DB >> 11748644

Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.

Evgeny Yakirevich1, Oleg Lefel, Yanina Sova, Avi Stein, Oded Cohen, Ofer Ben Izhak, Murray B Resnick.   

Abstract

Testicular seminoma is characterized by a prominent lymphoid infiltrate and an excellent prognosis. Cytotoxic T-lymphocytes (CTLs) infiltrating seminoma tumour nests constitute a major subset of the lymphoid infiltrate. The objective of this study was to determine whether CTLs express markers of cytotoxic potential and activity and whether the number of activated CTLs correlates with the extent of apoptosis in testicular seminomas, as opposed to non-seminomatous testicular germ cell tumours (NSTGCTs). Twenty cases of pure seminoma as well as 20 cases of NSTGCTs including 16 mixed germ cell tumours (MGCTs) were studied. Immunohistochemistry for the cytotoxic markers TIA-1 (cytotoxic potential) and granzyme B (cytotoxic activity) and the T-cell markers CD3 and CD8 was performed on formalin-fixed, paraffin-embedded sections. The apoptotic index (AI) was determined by the TUNEL method. The number of CD3(+), CD8(+), TIA-1(+), and granzyme B(+) cells in tumour cell nests was markedly increased in testicular seminomas, compared with NSTGCTs (p<0.01). Activated granzyme B(+) cells numbered 25.6+/-5.2 per high power field in seminomas and 8.9+/-3.2, 8.1+/-3.9, and 0.4+/-0.2 for embryonal carcinomas, yolk sac tumours, and immature teratomas, respectively. Double immunohistochemical staining for granzyme B and CD8 revealed that 82.6+/-8.5% of granzyme B-expressing cells were CD8(+). The tumour cell AI was significantly increased in embryonal carcinoma, compared with the seminoma, yolk sac tumour, and immature teratoma subgroups (6.7+/-1.3, 2.3+/-0.3, 3.0+/-1.1, and 2.3+/-1.1, respectively, p<0.001). TUNEL/CD3 double immunostaining revealed that a significant proportion of the apoptotic seminomatous tumour cells were in direct contact with one or more CD3(+) lymphocytes (47.2+/-6.2%). The number of activated granzyme B(+) CTLs showed a strong linear correlation with the AI in the seminoma group (r=0.71, p<0.0001) but not in other subgroups. TUNEL/granzyme B double immunolabelling revealed that a proportion of activated granzyme B(+) lymphocytes (20%) were often seen in close contact with apoptotic tumour cells. The presence of increased numbers of activated cytotoxic lymphocytes in testicular seminomas suggests that apoptotic tumour cell death in this neoplasm may be triggered by cytotoxic granule effectors. This phenomenon may be one of the key host immune mechanisms leading to the excellent prognosis in this tumour. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 11748644     DOI: 10.1002/path.996

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling.

Authors:  Peter J Siska; Romany A N Johnpulle; Alice Zhou; Jennifer Bordeaux; Ju Young Kim; Bashar Dabbas; Naveen Dakappagari; Jeffrey C Rathmell; W Kimryn Rathmell; Alicia K Morgans; Justin M Balko; Douglas B Johnson
Journal:  Oncoimmunology       Date:  2017-03-20       Impact factor: 8.110

2.  Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.

Authors:  Renata Boldrini; Maria Debora De Pasquale; Ombretta Melaiu; Marco Chierici; Giuseppe Jurman; Maria Chiara Benedetti; Nunzio C Salfi; Aurora Castellano; Paola Collini; Cesare Furlanello; Vito Pistoia; Loredana Cifaldi; Monica Terenziani; Doriana Fruci
Journal:  Oncoimmunology       Date:  2018-12-13       Impact factor: 8.110

Review 3.  The Good, the Bad and the Ugly of Testicular Immune Regulation: A Delicate Balance Between Immune Function and Immune Privilege.

Authors:  Gurvinder Kaur; Kandis Wright; Saguna Verma; Allan Haynes; Jannette M Dufour
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Comparative analysis of different apoptosis detection methods in human testicular cancer.

Authors:  Hans Ulrich Schmelz; Michael Abend; Matthias Port; Michael Schwerer; Ekkehard W Hauck; Wolfgang Weidner; Christoph Sparwasser
Journal:  Urol Res       Date:  2004-04-29

5.  Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer.

Authors:  Kristen M Drescher; Poonam Sharma; Patrice Watson; Zoran Gatalica; Stephen N Thibodeau; Henry T Lynch
Journal:  Fam Cancer       Date:  2009-01-23       Impact factor: 2.375

6.  Pure choriocarcinoma of testis with tumor-infiltrating lymphocytes and granulomas.

Authors:  Jai Hyang Go
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

7.  Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers.

Authors:  João Lobo; Ângelo Rodrigues; Rita Guimarães; Mariana Cantante; Paula Lopes; Joaquina Maurício; Jorge Oliveira; Carmen Jerónimo; Rui Henrique
Journal:  Cancers (Basel)       Date:  2019-10-11       Impact factor: 6.639

8.  Low tumor cell content predicts favorable prognosis in germinoma patients.

Authors:  Hirokazu Takami; Kaishi Satomi; Kohei Fukuoka; Shintaro Fukushima; Yuko Matsushita; Kai Yamasaki; Taishi Nakamura; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Tomonari Suzuki; Takaaki Yanagisawa; Hideo Nakamura; Kazuhiko Sugiyama; Kaoru Tamura; Taketoshi Maehara; Mitsutoshi Nakada; Masahiro Nonaka; Akio Asai; Kiyotaka Yokogami; Hideo Takeshima; Toshihiko Iuchi; Yonehiro Kanemura; Keiichi Kobayashi; Motoo Nagane; Kazuhiko Kurozumi; Koji Yoshimoto; Masahide Matsuda; Akira Matsumura; Yuichi Hirose; Tsutomu Tokuyama; Toshihiro Kumabe; Yoshitaka Narita; Soichiro Shibui; Yoichi Nakazato; Ryo Nishikawa; Masao Matsutani; Koichi Ichimura
Journal:  Neurooncol Adv       Date:  2021-08-10

9.  Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.

Authors:  Grégoire Wieërs; Nathalie Demotte; Danièle Godelaine; Pierre Van der Bruggen
Journal:  Cancers (Basel)       Date:  2011-07-18       Impact factor: 6.639

Review 10.  Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Authors:  Michal Chovanec; Ugo De Giorgi; Michal Mego
Journal:  Adv Urol       Date:  2018-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.